Birgitte Giersing

World Health Organization

Team Lead, Vaccine Platforms & Prioritization, and new TB Vaccines

Switzerland

Dr Birgitte Giersing is a team lead in the Product and Delivery Research Unit, in the Immunization, Vaccines and Biologicals (IVB) department, WHO. She leads IVB’s work on new TB vaccines, and the TB Vaccine Accelerator secretariat within the Science Division. As the secretariat for IVB’s Product Development for Vaccines Advisory Committee (PDVAC), her role includes establishing new tools and mechanisms to identify vaccine R&D priorities, and to effectively partner with country, regional and global immunization stakeholders to accelerate regulatory approval and uptake in low- and middle-income countries. Birgitte has been at WHO for almost 10 years, and previously held vaccine product development roles in industry and the non-profit sector.

Birgitte Giersing

World Health Organization

Team Lead, Vaccine Platforms & Prioritization, and new TB Vaccines

Dr Birgitte Giersing is a team lead in the Product and Delivery Research Unit, in the Immunization, Vaccines and Biologicals (IVB) department, WHO. She leads IVB’s work on new TB vaccines, and the TB Vaccine Accelerator secretariat within the Science Division. As the secretariat for IVB’s Product Development for Vaccines Advisory Committee (PDVAC), her role includes establishing new tools and mechanisms to identify vaccine R&D priorities, and to effectively partner with country, regional and global immunization stakeholders to accelerate regulatory approval and uptake in low- and middle-income countries. Birgitte has been at WHO for almost 10 years, and previously held vaccine product development roles in industry and the non-profit sector.